Merriman Curhan Ford Initiates Coverage on the Communications/Wireless Technology Sector Feb 2, 2010 09:20AM

SAN FRANCISCO, Feb. 2 /PRNewswire-FirstCall/ -- Merriman Curhan Ford (Nasdaq: MERR) today announced that it has initiated coverage on the Communications: Wireless Technology sector under equity research analyst Scott Searle, CFA. (Logo: http://www.newscom.com/cgi-bin/prnh/20090911/MCFLOGO) Searle's research thesis includes company coverage of Alvarion Ltd. (ALVR), Aviat Networks, Inc. (AVNW), Brightpoint Inc. (CELL), Cogo Group, Inc. (COGO), RF Micro Devices, Inc. (RFMD), Smith Micro Software, Inc. (SMSI) and TriQuint Semiconductor, Inc. (TQNT) with Buy ratings and Palm, Inc. (PALM), Ceragon Networks, Ltd. (CRNT), DragonWave Inc. (DRWI) and PowerWave Technologies Inc. (PWAV) with Neutral ratings. Searle highlighted these themes in his company initiation reports: -- Alvarion Ltd. (NASDAQ:ALVR $4.06; Buy) Historically overhyped and often confused as a 4G competitor to LTE, WiMAX is a real and commercially ready broadband wireless solution that supports speeds of up to 40Mbps (going to 300Mbps). Despite the global credit freeze and ensuing recession, WiMAX has over 500 deployments in 147 ...


Unusual 11 Mid-Day Movers 6/17: SVNT, MIPI, MEA, ALVR Higher; STSI, AHT, ARM, AXL Lower Jun 17, 2009 12:19PM

Star Scientific, Inc. (Nasdaq: STSI) 76.4% LOWER; R.J. Reynolds Tobacco Company (NYSE: RAI) today announced a jury verdict in favor of the company in a patent infringement lawsuit brought by Star Scientific in the U.S. District Court for Maryland - Northern Division. Click here for the full report.

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) 32.4% HIGHER; announced that the Arthritis Advisory Committee appointed by the FDA recommended by a vote of 14 to 1 that KRYSTEXXA, a biologic PEGylated uricase enzyme, be granted marketing approval by the FDA for the treatment of refractory chronic gout. Click here for the full report. Also affecting the stock this ...


Morning Movers 6/17: MERX, CYTR, SVNT, MIPI, TSTR Higher; ETFC, CTIC, AIB Lower Jun 17, 2009 09:48AM

Merix Corporation (NASDAQ: MERX) 35.1% HIGHER; announced a major, multi-million dollar order from global avionics and communications pioneer Rockwell Collins (NYSE: COL). The order is a direct result of Merix's focus on the defense and aerospace sector where the company has broadened its product offering and grown its market share in the past 14 months.

CytRx Corporation (NASDAQ: CYTR) 33.8% HIGHER; announced that tamibarotene, currently under evaluation in a U.S. registration trial as a third-line treatment for acute promyelocytic leukemia, showed statistically significant anti-tumor activity in human myeloma cells transplanted into animals. Multiple myeloma is an incurable malignant tumor of the plasma cells of bone marrow. Results of the trial were published in the June 2009 peer-reviewed journal Cancer Science (Volume 100, No. 6, Pages 1137-1143).

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) 28.4% HIGHER; announced ...